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Disease modeling is increasingly being used to evaluate the effect of health intervention 
strategies, particularly for infectious diseases. However, the utility and application of 
such models are hampered by the inconsistent use of infectious disease modeling terms 
between and within disciplines. We sought to standardize the lexicon of infectious disease 
modeling terms and develop a glossary of terms commonly used in describing models’ 
assumptions, parameters, variables, and outcomes. We combined a comprehensive 
literature review of relevant terms with an online forum discussion in a virtual commu-
nity of practice, mod4PH (Modeling for Public Health). Using a convergent discussion 
process and consensus amongst the members of mod4PH, a glossary of terms was 
developed as an online resource. We anticipate that the glossary will improve inter- and 
intradisciplinary communication and will result in a greater uptake and understanding of 
disease modeling outcomes in heath policy decision-making. We highlight the role of 
the mod4PH community of practice and the methodologies used in this endeavor to link 
theory, policy, and practice in the public health domain.
Keywords: infectious disease modeling, reproduction number, community of practice, lexicon of terms, public health
iNTRODUCTiON
Mathematical and computational models are useful tools to provide important information on 
key aspects of infectious disease epidemiology. Models can assist in quantifying the transmission 
potential of a pathogen within a population, as well as assessing the effects of various control and 
prevention strategies. In times of uncertainty, public health responses may be based on expected 
outcomes obtained from models (1), especially in the event of new emerging or re-emerging diseases. 
However, such outcomes are reliant on assumptions, terms, parameters, and their definitions and 
inter-relations (2). Models are also updated over time as empiric data accumulates, incorporating 
biological, epidemiological, and immunological data, as well as more realistic assumptions with 
the inclusion of individual-level health and behavioral responses. The use of modeling by public 
health decision makers is still limited, perhaps due in large part to the inconsistent use of modeling 
and disease-related terminology across models and disciplines (3). For example, a recent review 
of influenza modeling literature highlighted the discrepancies in the definition of terms used in 
different studies (4). Such discrepancies often arise from a model’s assumptions, methodological 
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approaches used to analyze a model, and outdated definitions that 
do not reflect current knowledge.
Ambiguities caused by inconsistent use of terms in models 
can have enormous impact on model design, usefulness for 
public health, and understanding and comparability of model 
outcomes. Standardization of the terms used in modeling could 
improve this process and its applications. In recent years, con-
siderable efforts have been made to develop unity of thought 
about modeling approaches in health sciences, including the 
particular case of infectious diseases (5). For example, there 
have been efforts to improve the use of disease modeling 
terminology through the creation of topic specific glossaries 
(6, 7). While such glossaries define commonly used terms and 
provide an understanding of the vocabulary and methods used 
in the disease modeling literature (3, 4, 6, 7), they do not aim 
at standardizing a common lexicon based on infectious disease 
terminology. Furthermore, the existing modeling glossaries do 
not take into account the spectrum of definitions of terms used 
by various health disciplines such as public health, epidemiol-
ogy, and clinical medicine.
To address this gap, we developed a multidisciplinary dialog 
between the members of a recently established virtual “Community 
of Practice,” called mod4PH (Modeling for Public Health) (8), 
whose goal is to enhance the understanding of modeling, and 
its applications for public health and clinical decision-making 
related to infectious disease prevention and control. The mod4PH 
group, a LinkedIn forum, consists of individuals from different 
disciplines including disease modeling, public health, infectious 
disease epidemiology, and policy analysis. The objective of the 
current study in the mod4PH group was to produce a “glossary of 
terms,” which describes the standard use and definition of infec-
tious disease modeling terms. This glossary and the guidelines 
for the use of terms were developed based on literature review, 
online discussion among mod4PH participants, and subsequent 
consensus. Here, we discuss the process by which the glossary was 
created and provide a summary of the online forum discussions 
surrounding the usage and definition of key terms in modeling 
infectious diseases.
MATeRiALS AND MeTHODS
A comprehensive literature review of infectious disease terms 
used in modeling studies was combined with an online discus-
sion in “mod4PH,” a predominately social media platform 
complemented by a face-to-face annual meeting. Considering 
the importance of a standard lexicon of terms in understanding 
modeling outcomes and their comparability, we discussed several 
key terms that are commonly used in disease models.
mod4PH Community of Practice
Sponsored by the National Collaborating Center for Infectious 
Diseases (NCCID), Canada, mod4PH represents a virtual 
community of practice that promotes the best procedures for 
research activities and collaborations and integrates resources 
and expertise for knowledge translation to improve the uptake 
of infectious disease modeling (8). The mod4PH community of 
practice currently hosts members from various disciplines and 
geographic locations and recruits individuals with the required 
expertise and experience relevant to its mandate.
The mod4PH forum was initially established with a number of 
participants from the face-to-face 2014 Pan-InfORM workshop 
(9). Following the inception of mod4PH, NCCID announced 
the forum on Twitter, electronic mail, and other media in 
order to reach out to modelers and medical and public health 
professionals to enhance the depth and breadth of expertise in 
the forum. At the time of this study, there were 77 mod4PH 
members of whom approximately 50% were modelers, and the 
remaining were from other relevant disciplines as indicated by 
information included in their LinkedIn profiles. The majority 
of mod4PH members are located in North America (Canada 
and the United States). Members from Western and Southern 
Europe, South Central Asia, South America, and Australia and 
New Zealand constitute approximately one-fifth of the forum.
Development of Common Lexicon
The literature review was conducted for specific terms that are 
used in peer-reviewed published articles in a wide array of jour-
nals published in English. The search engines “PubMed,” “Google 
Scholar,” “Web of Science,” and “Scopus” were used to find terms 
used in both mathematical epidemiology and public health with 
an ambiguous and discrepant definition. We also consulted a 
previous review of terms in modeling influenza infection, which 
relied on a variety of sources including systematic reviews, peer-
reviewed published articles, books, advisory health reports, and 
websites of public health agencies and organizations (e.g., World 
Health Organization, U.S. Centers for Disease Prevention and 
Control, Public Health Agency of Canada, and European Center 
for Disease Control) (4).
We considered essential terms that are used often in epidemio-
logical models of infectious diseases with two main criteria: (i) a 
term was defined differently between articles or (ii) two different 
terms were used interchangeably, with the threshold that one of 
the criteria is met in at least two peer-reviewed articles. Terms 
and definitions identified in the review of relevant studies were 
classified as “discussion topics” based on their definitions and 
usage. Each week, a discussion topic and the associated refer-
ences were posted on the mod4PH forum (8), which remained 
active for the period of study between November 2015 and April 
2016. The topics typically opened with a question or comment on 
inconsistent terms that would draw members of the forum with 
relevant expertise into the discussion. A total of 25 terms were 
discussed in 13 discussion sessions (10).
Forum Discussion
For the purpose of this study, a convergent discussion process 
was followed (11), which involved a technique that allowed par-
ticipants to not only provide feedback on the discussion topic but 
also propose questions with the flexibility to probe and explore 
emerging issues in different contexts (e.g., epidemiological, 
clinical, public health, modeling, and specific disease or popula-
tion). Convergence was achieved by asking probing questions 
that became progressively more detailed and specific in order to 
clarify the definitions and appropriate use of terms in models. 
The general nature of questions and ensuing discussions led the 
FiGURe 1 | Possible timelines and various stages of disease with their relationship in the SeiR model. The terms latent, infectious, and non-infectious are 
transmission-related, and the remaining terms are all progression-related.
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forum participants to highlight the relevance of each term to the 
conceptual modeling frameworks, identify the most commonly 
used lexicon with reference to published studies in different dis-
ciplines, and challenge, change, or confirm emerging interpreta-
tions to develop a glossary of terms that can be used to standardize 
the vocabulary in models. New topics were introduced each week 
and remained open for discussion for the duration of the project 
to: (i) increase understanding and clarity of modeling terms for 
their definition and use, (ii) challenge emerging issues in closely 
relevant concepts and terminologies of infectious diseases, and 
(iii) ensure that the study of terms was not prematurely closed.
MODeLiNG TeRMS, PARAMeTeRS, AND 
THeiR ReLATiONS
Models of infectious disease dynamics are developed to reflect: 
(i) the biology of the infectious agent and (ii) the physiological 
processes and attributes of the disease at both the individual and 
population levels. These are defined by: (a) the time course of 
the stages of disease progression through the infection process, 
from exposure to recovery or death (which constitutes the area of 
clinical medicine) and (b) a time course of states of transmission 
potential from exposure to post infectiousness (which constitutes 
the area of public health and epidemiology) (12). The biology 
of the infectious agents and the pathophysiological processes 
include the disease statuses of the individuals, which determine 
the susceptibility of individuals to infection or transmissibility 
of the disease. The change of status described in models is often 
linked to the spread of disease characterized by the population-
level phenomena of disease incidence or prevalence, as well as 
parameters affecting these phenomena such as the generation 
interval and serial interval. In the following sections, we report 
on the outcomes of discussions from the online mod4PH forum 
on the relevant modeling terms.
Compartmental Models
In most disease dynamic models, a compartmental structure 
is developed that divides the population into several classes of 
individuals according to their epidemiological statuses. These 
include: susceptible (S), exposed (E), infectious (I), and recovered 
(R), and their relationship describes a basic disease transmission 
dynamic model, referred to as the classical SEIR model (Figure 1) 
(13). Although other context and disease-specific compartments 
may be added, in this paper, we restrict our attention to this basic 
framework. Individuals may transition between these classes 
as a change of status occurs due to disease-related processes. 
These models may be used to compute quantities such as the 
basic reproduction number and the prevalence and incidence of 
disease in the population (13).
Susceptible, infected, and Recovered
Susceptible refers to a non-infected individual (or population) 
who may become infected through contact with individuals 
or environmental organisms that can transmit the disease. 
Individuals may show varying degrees of susceptibility based on a 
number of host factors (e.g., immunity; see “Individual Immunity 
and Herd Immunity”). Successful transmission of the pathogen 
to a susceptible individual will result in the susceptible individual 
becoming infected, either clinically or subclinically. However, 
even in the absence of successful transmission, the susceptible 
individual is referred to as “exposed” (as used in epidemiology and 
other health-related disciplines). In contrast, in compartmental 
models of disease transmission, the exposed compartment is used 
to label individuals as “infected,” with the assumption of success-
ful transmission. It is assumed that individuals in the exposed 
class are incapable of transmitting the disease, unlike those in the 
infectious compartment.
In disease dynamic models, infected individuals are often con-
sidered to be infectious, that is, they are capable of transmitting 
the disease. When this classification is made, it is important for 
the model to clearly state that these individuals are both “infected 
and infectious” since the assumption of infectivity is inconsistent 
with the epidemiological observation that an infected individual 
is not necessarily infectious.
For a disease in which the causative pathogen can be eliminated 
from the infected person or become dormant, the infectious stage is 
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followed by a non-infectious stage. Models of disease transmission 
dynamics refer to this non-infectious stage as “recovered,” since 
the individuals in this stage can no longer transmit the disease. 
However, we note that, in the epidemiological and clinical con-
texts, a non-infectious individual is not necessarily pathogen-free.
exposed and Latent
In most disease transmission dynamic models, the term 
“exposed” is used to refer to individuals who are infected but are 
not yet capable of transmitting the disease (14, 15). However, this 
concept is inconsistent with the observation used in epidemiol-
ogy referring to susceptible individuals who have been in contact 
with infectious individuals, but the success of transmission is 
not determined. When the exposure to the infectious individual 
occurs with successful pathogen transmission to a susceptible 
individual, this leads to colonization or infection. To improve a 
model that includes an exposed compartment, it is suggested to 
use the term “latent” to represent the class of individuals who 
have been infected following exposure to disease but are not yet 
capable of transmitting the disease.
The term “latent” describes an infected individual who cannot 
transmit the pathogen, regardless of the time for exposure to the 
pathogen. For a number of infectious diseases (e.g., influenza), 
the individual becomes latent immediately following the expo-
sure to pathogen when transmission occurs (14, 15). However, it 
is important to note that an individual may be latent at a different 
stage of disease. For example, individuals with tuberculosis can 
have active infection in which they shed bacteria or latent infec-
tion (possibly after an effective course of treatment) in which 
there are no clinical symptoms and no pathogen transmission, 
but the bacteria is still present in the body (16, 17). We note that, 
in clinical infectious diseases, latency can occur before symptoms, 
without symptoms, or after symptoms.
Periods: Latent, incubation, and infectious
The latent period refers to the period of time between exposure 
to a disease with successful transmission and the onset of infec-
tiousness. During the latent period, infected individuals do not 
transmit the disease. This period has commonly been referred to 
as the “exposed period” in infectious disease modeling; however, 
the exposed period may suggest a period of time during which 
the event of exposure to disease continually occurs, rather than 
a period of time following exposure. It is therefore suggested 
that the “latent period” should be used as the standard lexicon in 
models of disease transmission.
The incubation period is defined as the period of time between 
exposure to the disease (if transmission occurs) and the onset 
of clinical symptoms. For diseases in which the onset of infec-
tiousness coincides with the appearance of symptoms, the latent 
and incubation periods are the same. However, in a number of 
diseases (e.g., influenza, measles, and varicella), the infected 
individual may become infectious before the onset of symptoms. 
For such diseases, the models may account for the incubation 
period by including the latent and presymptomatic periods (see 
“Presymptomatic and Asymptomatic”).
The infectious period is defined as the time interval in which 
the infected individual is capable of transmitting the disease. 
Since this period may overlap with the incubation period, it may 
be difficult to obtain accurate estimates of the infectious period.
incidence and Prevalence
Disease incidence is defined by both epidemiologists and model-
ers as the number of new cases in a population generated within 
a certain time period. In SEIR models, it is often calculated as 
the product of the number of susceptible individuals, the number 
of infected individuals (who are considered infectious and can 
transmit the disease), and the transmission rate per contact 
per unit of time. In continuous time models, the incidence of a 
disease is measured at a single time point and typically represents 
the rate at which the infected population changes. However, in 
discrete time models (18), the incidence is considered over a 
time period, which may represent the average generation interval 
(see “Generation Interval and Serial Interval”). If the generation 
interval is sufficiently small, then the definitions of incidence 
in continuous and discrete time models converge. Due to the 
discrepancy in these definitions (4), it has been suggested that, in 
continuous models, referring to the measure as “instantaneous 
incidence” may be more appropriate than incidence.
Disease prevalence is defined as the number of cases of a 
disease at a single time point in a population. In compartmental 
models, the prevalence is represented by the number of infectious 
individuals at any time.
The Basic Reproduction Number (R0)
The basic reproduction number is defined as the average number 
of secondary cases caused by a single infectious individual in a 
totally susceptible population (19). This quantity is often used in 
deterministic compartmental models to determine whether an 
epidemic (in a demographic-free model) or endemic (in a model 
with demographics) will occur (R0 > 1) or if the disease will go 
extinct before causing an epidemic or endemic (R0 < 1). The case 
of R0 = 1 is referred to as a disease endemic, in which each case 
generates on average one additional case (20).
While there is a broad agreement on the definition of the 
reproduction number, recent studies show that the methodol-
ogy and type of model used to calculate R0 may lead to different 
estimates (21, 22). Furthermore, variability in these estimates has 
raised concern about whether R0 should be used to determine 
the occurrence of an epidemic or endemic (21). In the context of 
simple susceptible-infectious-recovered (SIR) models, R0 is often 
derived from a relationship between the transmission rate and the 
infectious period (23). The simplest SIR epidemic model without 
demographics can be expressed by (13)
 
dS
dt
incidence = SI
N
dI
dt
incidence recovery = SI
dR
= − −
= − −
β
β
γ
N
I
dt
recovery = = γI
 
where d( )
dt
⋅  represents the change in a variable over time, 
N = S + I + R is the total population size, β is the transmission 
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rate, and γ is the recovery rate. In this model, the inverse of the 
recovery rate (1/γ) represents the average length of the infectious 
period. At the early stages of an epidemic, the number of infected 
individuals is small compared to the number of susceptible 
individuals, which approximates the total population size and 
therefore S/N ≈ 1. This approximation simplifies the equation for 
the prevalence to
 
dI
dt
 = −β γI I
 
Defining the quantity R0 = β/γ as the reproduction number 
(13) and solving the prevalence equation gives the solution 
I t I e R t( ) = − 0 10γ( ) , where I0 is the initial number of infections at the 
onset of the epidemic. This solution provides an approximation 
for the exponential growth of the prevalence at the early stages 
of an epidemic when R0 > 1. In order to illustrate the relation-
ship between R0, the prevalence, and the disease incidence, we 
rewrite the prevalence in the form of I′ = γR0I − γI, and add this 
equation to the equation for recovery, which gives the incidence 
by I′ + R′ = γR0I. This leads to the relation (24): incidence = γR0 
(prevalence), and therefore,
 
R D0 =






incidence
prevalence  
where D = 1/γ.
Presymptomatic and Asymptomatic
The term “presymptomatic” describes a stage of disease in which 
an infected individual is infectious and can transmit the disease 
without presenting with symptoms. Individuals in the presymp-
tomatic stage will proceed to become symptomatic at some point 
of time in the future. In contrast, asymptomatic refers to a disease 
stage in which individuals are infectious but are not exhibiting 
disease symptoms.
For example, influenza has various stages, including an asymp-
tomatic stage in which individuals are capable of transmitting the 
disease but may have no knowledge of being infectious as they 
are not symptomatic. If these individuals develop a symptomatic 
infection, then the time period before the onset of symptoms is 
referred to as presymptomatic. A schematic representation of 
disease stages is illustrated in Figure 1.
Generation interval and Serial interval
In modeling, the generation interval refers to the period of time 
between the onset of the infectious period in a primary case to 
the onset of the infectious period in a secondary case infected 
by the primary case (25). In epidemiology, the serial interval is 
defined as the period of time between the onset of symptoms 
in a primary case to the onset of symptoms in a secondary case 
infected by the primary case (26). The generation interval is 
not an observable period based on symptoms since an infected 
individual may become infectious and transmit the disease before 
symptoms appear. However, the serial interval is an observable 
period that is determined with the onset of symptoms. When the 
infectious period starts with the onset of symptoms (i.e., the latent 
and incubation periods have the same duration), the generation 
interval coincides with the serial interval.
The use of these terms in modeling is disease-specific and 
depends on the transmission characteristics of the pathogen. For 
example, in influenza, the onset of infectiousness and symptoms 
may differ in an infected person, and therefore, the duration of 
the serial interval and the generation interval may not be the 
same. Using these measures, as has been done in published 
studies (25, 27), to estimate some of the key epidemiological 
parameters, such as the reproduction number, may result in dif-
ferent outcomes in terms of transmissibility of the disease as well 
as different recommendations for public health interventions. 
However, since models are often based on the infectious period 
and not the onset of symptoms, it may be more appropriate to 
use the generation interval for understanding the transmission 
dynamics and estimating related parameters such as the basic 
reproduction number (28).
individual immunity and Herd immunity
Immunity refers to protection against a disease. It can be 
acquired naturally in an individual by experiencing the disease 
and recovering from infection or by other means such as active 
vaccination or passive transfer of maternal antibody across the 
placenta (29, 30). Herd immunity refers to the protection level of a 
population as a result of individuals’ immunity against infection. 
Immunity in individuals (involving innate and adaptive T and B 
cell immune responses) can provide a wide range of protection 
from full (which completely prevents the occurrence of infection 
temporarily or permanently) to partial (which may not prevent 
infection but may reduce its severity and mitigate outcomes). The 
degree of an individual’s immunity determines their susceptibil-
ity to infection or reinfection. Immunity can be partial or full, 
as previously stated, based on host or pathogen characteristics, 
and can wane over time. Compartmental transmission dynamic 
models often include the protection effects of immunity by 
averaging the levels of immune protection in individuals. It is, 
however, important to note that this average may not correspond 
to the potential disease transmission or disease outcomes at the 
individual level. Studies in immuno-epidemiology models are 
addressing these issues (31, 32).
Attack Rate
The attack rate describes the proportion of the population that 
becomes infected over a specified period of time. For diseases 
for which not all infected individuals develop symptoms (e.g., 
influenza), it may be more informative to calculate the “clinical 
attack rate” (which measures the proportion of the population 
that develops disease symptoms as a result of an infection).
vaccine efficacy and effectiveness
In epidemiological and clinical studies, vaccine efficacy refers 
to the percentage reduction in the attack rate of the vaccinated 
cohort compared to the unvaccinated cohort as observed in a 
randomized controlled (field) trial. Vaccine effectiveness refers 
to the ability of a vaccine to prevent infection or related outcomes 
in the population in real-world conditions.
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The inclusion of vaccine-induced immunity in disease 
dynamic models is generally governed by the reduction of 
disease transmission to vaccinated individuals. This reduction 
is often based on a parameter that quantifies vaccine efficacy or 
effectiveness. While these two terms have different meanings 
and are measured using distinct methods (33), many models 
have used them interchangeably to imply the average protection 
level of individuals in the population. It is important to clearly 
distinguish between the two terms of efficacy and effectiveness, 
and models should consider vaccine effectiveness in the study of 
disease transmission dynamics in the population.
While neither vaccine efficacy nor effectiveness is measured 
with respect to time, the effect of a vaccine in individuals may 
change over time. This is reflected in the waning of vaccine-
induced immunity at the individual level and, as a result, the 
decline of herd immunity in the population. While there are 
various ways of including waning immunity in a model, it is 
important to note that a decline of immunity at the individual 
level over time is not equivalent to a decrease in vaccine efficacy 
or effectiveness.
DiSCUSSiON
Infectious disease modeling is an important epidemiological tool 
to inform strategies for disease control and prevention. Tracing 
its historical roots from the pioneering work of Daniel Bernoulli 
on smallpox in the 1760s (34) to the classical compartmental 
approach of Kermack and McKendrick in the 1920s (35, 36), 
modeling has evolved to incorporate demographic, geographic, 
and individual level characteristics, in addition to the most 
current knowledge of epidemiology, immunology, vaccines and 
drugs, and other public health interventions. This evolution is 
typified by advanced modeling and computational technologies, 
including metapopulation (37, 38), network (39), and agent-based 
simulation models (40, 41). From an epidemiological perspective, 
there are two important considerations that underlie the use of 
modeling tools, including disease progression-related terms (i.e., 
asymptomatic, presymptomatic, and symptomatic) and disease 
transmission-related terms (i.e., latent, infectious, and non-
infectious) (12). Given the complexity of the newer generation 
of models that comes with their flexibility, a standardized lexicon 
of terms can play an important role in understanding their 
outcomes and establishing effective communication within and 
between disciplines involved in infectious disease management.
While a number of studies exist that aim to clarify and define 
modeling terms and methodologies in the context of infectious 
diseases (3, 4, 6, 7) to the best of our knowledge, this is the first 
attempt to develop a glossary of terms through the expertise of 
a virtual community of practice. This community allowed for 
an increased accessibility and participation by international 
participants, as well as easy and convenient access to the ongo-
ing discussions. This initiative serves a larger goal envisioned 
for mod4PH, that is, to develop an international capacity and 
unified infrastructure that is capable of informing complex 
decision-making and improving health practices through the use 
of quality data, evidence, and scientific knowledge. The diversity 
of expertise in this community can help identify appropriate 
methods and modeling tools that can be used to assess the results 
and their comparability, share information on how models can 
best be used to inform policy, and enhance knowledge genera-
tion and translational activities in public and population health. 
Furthermore, this interdisciplinary nexus of constructive dialog 
can expand the training and research capacity beyond the 
traditional boundaries in academics and can enable consensus 
building and use of knowledge in a wider scientific community 
and international audience.
The diversity of the individuals in a community of practice 
does not come without its limitations. Various disciplines and 
backgrounds often use terms differently, and the lack of a com-
mon jargon-free language makes the process and intragroup 
discussions especially challenging. Furthermore, technical 
barriers to online forums (e.g., restrictions on the number of 
characters per post) may limit the extent of discussion that can 
take place in the platform. To improve communication between 
the mod4PH members, we implemented a convergent discussion 
process, enabling the discussion topics to remain active following 
their initiation in the online forum. This form of interdisciplinary 
engagement will ensure that, as our knowledge and understand-
ing of infectious disease mechanisms enhances, discussion topics 
are improved and definitions of pertinent terms and their use in 
modeling efforts are adapted and informed.
The resulting glossary of terms from the current initiative of 
mod4PH is published as an online resource by the NCCID (10). 
As the usage and definition of the terms discussed here evolve, the 
online glossary will be updated to mirror the necessary changes 
and ensure that it remains a current reference for infectious 
disease modeling as an important tool that is increasingly applied 
to effectively respond to public health threats. This initiative 
is concordant with a key element of the 2016 “World Health 
Organization Research and Development Blueprint” for infec-
tious diseases with epidemic potential (42), which calls for the 
international community to invest to improve its collective ability 
to respond to new threats and to prepare itself with a novel 
research and development paradigm to address future epidemics 
of newly emerging or re-emerging diseases.
While this study serves to bridge the gaps in modeling efforts 
and forge strong links between theory, policy, and practice, there 
remain many terms for ongoing discussion toward standardizing 
terminology, which are integral to the application of modeling 
outcomes to policy decision-making. We hope to use this study 
as a starting point to foster bidirectional communication between 
the involved disciplines, and improve the utility of modeling as 
an invaluable tool in the fight against persistent and emerging 
infectious diseases.
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